{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:39:40Z","timestamp":1787499580091,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Chemistry, Faculty of Science, Ataturk University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.12.028","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T03:34:45Z","timestamp":1545276885000},"page":"511-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"special_numbering":"C","title":["Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity"],"prefix":"10.1016","volume":"84","author":[{"given":"Dilan","family":"Ozmen Ozgun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Inci","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Yamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhami","family":"Gulcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sukuroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2018.12.028_b0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ncl.2007.03.008","article-title":"Alzheimer's disease and mild cognitive impairment","volume":"25","author":"Kelley","year":"2007","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bioorg.2018.12.028_b0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.02.035","article-title":"Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead","volume":"148","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2018.12.028_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14756366.2016.1226298","article-title":"Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"32","author":"Soyer","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2018.12.028_b0020","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm701253t","article-title":"Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors","volume":"51","author":"Butini","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bioorg.2016.05.002","article-title":"Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies","volume":"67","author":"Chigurupati","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2018.12.028_b0030","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1586\/ern.10.105","article-title":"Cholinesterase inhibitors: beyond Alzheimer's disease","volume":"10","author":"Larner","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bioorg.2018.12.028_b0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopha.2017.12.053","article-title":"Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease","volume":"98","author":"Kumar","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bioorg.2018.12.028_b0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2018.12.028_b0045","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.bioorg.2018.12.028_b0050","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/jm0108202","article-title":"Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties","volume":"45","author":"Scozzafava","year":"2002","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2018.12.028_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10787-016-0270-7","article-title":"Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives","volume":"24","author":"Domiati","year":"2016","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.bioorg.2018.12.028_b0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.bioorg.2018.12.028_b0065","first-page":"4566","article-title":"Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis","volume":"56","author":"Reddy","year":"1996","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2018.12.028_b0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/156802607780636717","article-title":"Dual carbonic anhydrase\u2013cyclooxygenase-2 inhibitors","volume":"7","author":"Dogne","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2018.12.028_b0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2016.1154534","article-title":"Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2018.12.028_b0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejmech.2018.01.024","article-title":"Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells","volume":"145","author":"Wei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2018.12.028_b0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/molecules21030271","article-title":"Biological validation of novel polysubstituted pyrazole candidates with in vitro anticancer activities","volume":"21","author":"Fahmy","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.12.028_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","article-title":"Pyrazole-pyrazoline as promising novel antimalarial agents: A mechanistic study","volume":"149","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2018.12.028_b0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/fmc-2017-0144","article-title":"Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity","volume":"10","author":"Eid","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0100","first-page":"126","article-title":"N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening, and computational studies","volume":"17","author":"Tripathi","year":"2018","journal-title":"EXCLI J."},{"issue":"4","key":"10.1016\/j.bioorg.2018.12.028_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/1573406413666171020114105","article-title":"Synthesis, cytotoxicity evaluation, molecular docking and utility of novel chalcones as precursors for heterocycles incorporating pyrazole moiety","volume":"14","author":"Gomha","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejmech.2018.01.026","article-title":"Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol\/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"145","author":"ElBordiny","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2018.12.028_b0120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cbdd.13149","article-title":"Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes","volume":"91","author":"Yamali","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2018.12.028_b0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2018.12.028_b0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14756366.2016.1254207","article-title":"Microwave-assisted synthesis and bioevaluation of new sulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"sup4","key":"10.1016\/j.bioorg.2018.12.028_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14756366.2016.1217852","article-title":"Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines","volume":"31","author":"Kucukoglu","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2018.12.028_b0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neulet.2005.03.028","article-title":"1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases","volume":"382","author":"Ucar","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2018.12.028_b0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","article-title":"Designing, synthesis, and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2018.12.028_b0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2016.1244533","article-title":"Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2018.12.028_b0155","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0160","doi-asserted-by":"crossref","unstructured":"H.I. Gul, M. Tugrak, M. Gul, H. Sakagami, N. Umemura, B. Anil, Synthesis and cytotoxicities of new azafluorenones with apoptotic mechanism of action and cell cycle analysis, Anticancer Agents Med. Chem. May 24, 2018. https:\/\/doi.org\/10.2174\/1871520618666180525085445.","DOI":"10.2174\/1871520618666180525085445"},{"issue":"1","key":"10.1016\/j.bioorg.2018.12.028_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14756366.2015.1014474","article-title":"Synthesis of some acrylophenones with N-methylpiperazine and evaluation of their cytotoxicities","volume":"31","author":"Gul","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.toxrep.2015.09.009","article-title":"Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells","volume":"2","author":"Sakagami","year":"2015","journal-title":"Toxicol. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2018.12.028_b0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3109\/14756366.2015.1070263","article-title":"Synthesis of mono Mannich bases of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one and evaluation of their cytotoxicities","volume":"31","author":"Tugrak","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"sup3","key":"10.1016\/j.bioorg.2018.12.028_b0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14756366.2016.1209495","article-title":"Synthesis and bioactivity studies of 1-aryl-3-(2-hydroxyethylthio)-1-propanones","volume":"31","author":"Unluer","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"sup4","key":"10.1016\/j.bioorg.2018.12.028_b0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14756366.2016.1221825","article-title":"Synthesis and bioactivities of halogen-bearing phenolic chalcones and their corresponding bis Mannich bases","volume":"31","author":"Yamali","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2018.12.028_b0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/14756366.2014.940934","article-title":"Synthesis and biological evaluation of 1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one and its aminomethyl derivatives","volume":"30","author":"Yerdelen","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.12.028_b0195","first-page":"550","article-title":"Pyrazoline derived new \u201coff-on-off\u201d fluorescent pH sensors","volume":"84","author":"Bozkurt","year":"2018","journal-title":"Opt. Mater. (Amsterdam, Netherlands)"},{"issue":"10","key":"10.1016\/j.bioorg.2018.12.028_b0200","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s00044-018-2242-5","article-title":"Cytotoxicity, apoptosis, and QSAR studies of phenothiazine derived methoxylated chalcones as anticancer drug candidates","volume":"27","author":"Gul","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.12.028_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bioorg.2018.03.006","article-title":"Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methyl piperazine-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K\/AKT\/mTOR and PKC-theta signaling pathways in human breast carcinoma cells","volume":"78","author":"Badr","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2018.12.028_b0210","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00044-017-1911-0","article-title":"Synthesis and structure elucidation of 1-(2, 5\/3, 5-difluorophenyl)-3-(2, 3\/2, 4\/2, 5\/3, 4-dimethoxyphenyl)-2-propen-1-ones as anticancer agents","volume":"26","author":"Yamali","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2018.12.028_b0215","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1871520617666170327123909","article-title":"Synthesis and cytotoxic activities of difluoro-dimethoxy chalcones","volume":"17","author":"Yamali","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2018.12.028_b0220","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/14756366.2016.1149479","article-title":"Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase","volume":"31","author":"Ozgun","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2018.12.028_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201700314","article-title":"Synthesis and biological evaluation of phloroglucinol derivatives possessing alpha-glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity","volume":"351","author":"Burmaoglu","year":"2018","journal-title":"Arch Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2018.12.028_b0230","article-title":"In vitro cytotoxic and in vivo antitumoral activities of some aminomethyl derivatives of 2,4-dihydro-3H-1,2,4-triazole-3-thiones-Evaluation of their acetylcholinesterase and carbonic anhydrase enzymes inhibition profiles","author":"Timur","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818313245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818313245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:46:11Z","timestamp":1758613571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818313245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"alternative-id":["S0045206818313245"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.12.028","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}